Raymond James Financial Services Advisors, Inc. Ironwood Pharmaceuticals Inc Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 15,584 shares of IRWD stock, worth $53,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,584
Previous 15,330
1.66%
Holding current value
$53,920
Previous $99,000
35.35%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding IRWD
# of Institutions
238Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$79.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$76.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$56.7 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$39 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$34.3 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $530M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...